Press release
Immunostimulatory Adjuvants Market - Size, Share, Outlook, and Forecast till 2026
Get Sample copy of research report: https://www.worldwidemarketreports.com/sample/196104
Immunologic adjuvants are majorly used to enhance vaccine potency by improvement of the humoral and/or cell-mediated immune response to vaccine antigens. This can be used to develop vaccine for prevention of various viral infections, which in turn is driving growth of the immunostimulatory adjuvants market. Therefore, development of vaccines with appropriate adjuvants is an attractive approach towards eliciting protective and long-lasting immunity in humans. The use of appropriate adjuvants allows vaccine formulations that selectively trigger innate immunity and/or adaptive immunity to obtain a desired type of antigen-specific immune responses. However, only a limited number of adjuvants is licensed for human vaccines due to complications regarding safety and toxicity, which is key factor restraining growth of the immunostimulatory adjuvants market.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/196104
Key developments of Immunostimulatory Adjuvants Market
Market players are engaged in developing novel vaccines containing immunostimulatory adjuvants in order to meet increasing demand from healthcare sector. Furthermore, approval of novel drugs and guidelines regarding utilization of adjuvants by regulatory bodies is fueling growth of the immunostimulatory adjuvants market. For instance, in May 2018, the Centers for Disease Control and Prevention's (CDC) Advisory Committee published guidance on use of Heplisav-B (HepB-CpG), a new vaccine that protects against hepatitis B virus (HBV) infection. The new vaccine is one of five approved inactivated HBV vaccines. Heplisav-B contains a novel immunostimulatory sequence adjuvant. Two doses are administered just 1 month apart, making it an important option for prevention of HBV.
In February 2018, researchers from Kawasaki Institute of Industrial Promotion, The University of Tokyo, Tokyo Medical and Dental University, and Osaka Prefecture University, enhanced adjuvant properties of the RNA by utilizing the high immunogenicity of double stranded (ds)RNA. The dsRNA comprised mRNA itself and an RNA strand complementary to the poly A region of the mRNA. The study aimed to develop significant immune stimulation in a cell line and bone-marrow-derived APCs in vitro. Key players operating in immunostimulatory adjuvants market include Recenttec, Bayer AG, Adjuvance Technologies, Vical, Allergy Therapeutics, and BioCentury.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunostimulatory Adjuvants Market - Size, Share, Outlook, and Forecast till 2026 here
News-ID: 1212740 • Views: …
More Releases from Worldwide Market Reports
Breast Implant Tissue Expander Market is Booming - Gaining Revolution in Eyes of …
The Breast Implant Tissue Expander Market research report not only assists newly entered businesses but also assists businesses of all levels, shapes, scope, experience levels and sizes. This Breast Implant Tissue Expander Market report provides the way to key organizations for the further expansion and business growth. Potential areas are spotted out in this market research report for the business expansion. Breast Implant Tissue Expander Market research report reveals important…
Glass Blood Collection Tubes Market is set to Fly High Growth in Years to Come | …
The Glass Blood Collection Tubes Market research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Glass Blood Collection Tubes industry along with various other factors over the predicted period 2024-2031. The overall business goal can be accomplished through this Glass Blood Collection Tubes Market study report as it consists of all the current scenarios and major…
Transmission Line Arrester Market - Major Technology Giants in Buzz Again | ABB, …
The Global Transmission Line Arrester Market is added by WMR to its database to offer a complete assessment of the factors influencing and overall market growth trend. The research covers significant data and proves to be a handy resource document for industry experts. The research is a perfect balance bridging both qualitative and quantitative information of this market. Quantitative statistics with qualitative reasoning related to market size, share, and influencing…
Portable Air Compressors Market Worldwide Industry Analysis, Future Demand, And …
The latest intelligence report published by WMR with the title "Portable Air Compressors Market - Growth Insights, Forecast to 2031" provides current updates and strategic steps taken by competition along with growth estimates of market size. This market study presents basic data and true figures about the market giving a deep analysis of this market based on market trends, market drivers, constraints, and prospects. The report supplies the worldwide monetary…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
